Autor: |
Zahraa Talib Khudhair, Shihab, Mehdi Salih, Hamah-Ameen, Baram |
Předmět: |
|
Zdroj: |
Russian Journal of Bioorganic Chemistry; Jul2021, Vol. 47 Issue 4, p789-804, 16p |
Abstrakt: |
The drug development process for Coronavirus disease (COVID-19) is the research process to create a preventive vaccine or therapeutic prescription drug to relieve the severity of 2019–2020 (COVID-19). In different stages of preclinical or clinical research, several hundred special scientific research centers, research organizations, and health agencies have developed and tried enormous numbers of vaccine candidates and new drugs for COVID-19 disease. In order to identify new therapies against COVID-19, several clinical trials have been in progress worldwide. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|